There could be several more updates soon. News on Brilacidin-OM, Brilacidin as an antibiotic, Kevetrin.... or a partnership. Or maybe Rosen will crumble and pay CTIX back for the 432,000 worth of options they paid the Ashcroft firm for legal fees? All kinds of potential catalysts here.

Pity the fool who is short CTIX.

(although I have no pity for them and hope that there is justice for their criminal activity)